NeoGene Receives French Financing
- Share via
NeoTherapeutics Inc. said its genomics research subsidiary, NeoGene Technologies Inc., has received $2 million in financing from French bank Societe Generale.
The bank received preferred stock that is convertible into a 4% stake in NeoTherapeutics, an Irvine biopharmaceutical company.
Proceeds from the sale will be used to fund the expansion and ongoing research of NeoGene.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
